The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Gilbert Halley E since year 2005.
The trader's CIK number is 1601360.
At the time of this reporting, Gilbert Halley E is the Chief Legal Officer of Ironwood Pharmaceuticals Inc .
(stock ticker symbol IRWD).
See this page for all insider trading activities at Ironwood Pharmaceuticals Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-01-30 | IRWD | Ironwood Pharmaceuticals Inc | Option Ex | 20,449 | 4.89 | 99,995 |
| 2018-07-03 | IRWD | Ironwood Pharmaceuticals Inc | Option Ex | 29,551 | 4.89 | 144,504 |
| 2018-07-03 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 29,551 | 19.75 | 583,632 |
| 2018-02-21 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 7,741 | 14.66 | 113,483 |
| 2017-06-22 | IRWD | Ironwood Pharmaceuticals Inc | Option Ex | 35,000 | 3.76 | 131,600 |
| 2017-06-22 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 35,000 | 19.75 | 691,250 |
| 2017-02-22 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 5,039 | 16.94 | 85,360 |
| 2017-02-14 | IRWD | Ironwood Pharmaceuticals Inc | Option Ex | 37,385 | 3.76 | 140,567 |
| 2017-02-14 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 37,385 | 16.75 | 626,198 |
| 2016-11-11 | IRWD | Ironwood Pharmaceuticals Inc | Option Ex | 14,000 | 3.76 | 52,640 |
| 2016-11-11 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 14,000 | 16.75 | 234,500 |
| 2016-05-25 | IRWD | Ironwood Pharmaceuticals Inc | Option Ex | 15,865 | 3.76 | 59,652 |
| 2016-05-25 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 20,275 | 12.19 | 247,152 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gilbert Halley E (Chief Legal Officer of Ironwood Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.